QELYDO Trademark

Trademark Overview

On Tuesday, November 29, 2011, a trademark application was filed for QELYDO with the United States Patent and Trademark Office. The USPTO has given the QELYDO trademark a serial number of 79108249. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, November 29, 2021. This trademark is owned by NOVARTIS AG. The QELYDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
qelydo

General Information

Serial Number79108249
Word MarkQELYDO
Filing DateTuesday, November 29, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, November 29, 2021
Registration Number4177699
Registration DateTuesday, July 24, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Translation of Words in MarkThe wording "QELYDO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, November 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, June 27, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, June 27, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2020NOTIFICATION PROCESSED BY IB
Friday, May 22, 2020NOTIFICATION PROCESSED BY IB
Thursday, October 10, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, October 10, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, December 9, 2016NOTIFICATION PROCESSED BY IB
Friday, December 11, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, December 11, 2015DEATH OF INTERNATIONAL REGISTRATION
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 18, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 26, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 26, 2012FINAL DISPOSITION PROCESSED
Wednesday, October 24, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 24, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 8, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 30, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 29, 2012ASSIGNED TO LIE
Friday, March 23, 2012REFUSAL PROCESSED BY IB
Tuesday, March 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 12, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 12, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 12, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 5, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 5, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 23, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 23, 2012REFUSAL PROCESSED BY MPU
Saturday, February 18, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 17, 2012NON-FINAL ACTION WRITTEN
Tuesday, February 14, 2012ASSIGNED TO EXAMINER
Friday, February 10, 2012APPLICATION FILING RECEIPT MAILED
Monday, February 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 3, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 2, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

qelydo disorders system preparations pharmaceutical diseases treatment prevention caused bacteria ophthalmology